WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) reported a profit for its third quarter that advanced from last year.
The company said its bottom line totaled $365 million, or $3.13 per share. This was up from $276 million, or $2.38 per share, in last year's third quarter.
The company said revenue for the quarter rose 7.0% to $1.22 billion. This was up from $1.14 billion last year.
Regeneron Pharmaceuticals earnings at a glance:
-Earnings (Q3): $365 Mln. vs. $276 Mln. last year. -Earnings Growth (Y-o-Y): 32.2% -EPS (Q3): $3.13 vs. $2.38 last year. -EPS Growth (Y-o-Y): 31.5% -Revenue (Q3): $1.22 Bln vs. $1.14 Bln last year. -Revenue Change (Y-o-Y): 7.0%
Copyright RTT News/dpa-AFX
© 2016 AFX News
